TY - JOUR AU - Rebuzzi, Sara Elena AU - Facchinetti, Francesco AU - Tiseo, Marcello PY - 2019 TI - Anti-angiogenesis boosts chemo-immunotherapy in patients with EGFR mutations or baseline liver metastases: insights from IMpower150 study JF - Translational Cancer Research; Vol 8, Supplement 6 (December 20, 2019): Translational Cancer Research Y2 - 2019 KW - N2 - The first-line treatment scenario of advanced non-small cell lung cancer (NSCLC) has been substantially revolutionized in the very last years, since immunotherapy has become a cornerstone. UR - https://tcr.amegroups.org/article/view/29602